Histogenics (HSGX) Misses Q2 EPS by 1c

August 11, 2016 8:13 AM EDT
Get Alerts HSGX Hot Sheet
Trade HSGX Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Histogenics (NASDAQ: HSGX) reported Q2 EPS of ($0.61), $0.01 worse than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Histogenics (HSGX) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment